![Loading Events](https://lifescievents.com/wp-content/plugins/the-events-calendar/src/resources/images/tribe-loading.gif)
Mapi Pharma: Glatiramer Acetate Depot: A Potential Long Acting Injection Solution for Multiple Sclerosis Patients
![Mapi pharma banner Mapi pharma banner](https://lifescievents.com/wp-content/uploads/2022/09/Mapi-pharma-banner.png)
DATE: | October 19, 2022 |
---|---|
TIME: | 10:30 AM EDT |
LOCATION: | Virtual |
About The Event
Join us for a KOL Event with Mapi Pharma, where neurologists Aaron Miller, MD (Mount Sinai) and Carlo Tornatore, MD (Georgetown University Medical Center) will discuss Mapi Pharma’s Phase 3 Glatiramer Acetate (GA) Depot clinical results and the contribution a monthly GA Depot could have on the treatment of multiple sclerosis (MS) patients.
Mapi Pharma’s Principal Investigator, experts and CEO will discuss the Phase 3 GA Depot study results and provide a company update. Additionally, the KOLs will provide a comprehensive overview on the treatment landscape for Relapsing Forms of MS (RMS) and the unmet medical need for a long-acting monthly injection as compared to the approved daily or 3x/week GA injection,commercially available as Copaxone®, and its generic versions.
A live Q&A session will follow the formal presentations.